Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,341
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,860
Class I recallsReasonable probability of serious health consequences
24,450
Class II recallsTemporary or medically reversible health consequences
2,901
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,095 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/haifa-smoked-fish-recalls-cold-smoked-sprats-due-potential-health-riskPublished October 27, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,450
Class I9,860
Class III2,901
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,450
Class I9,860
Class III2,901
Not Yet Classified2

Showing 7,621–7,640 of 17,329 recalls

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass I

Quinacrine Dihydrochloride (98.25%), bulk API product, packaged in a) 500 g NDC# 71052-530-05; b) 50 g NDC# 71052-530-55, c) 25g NDC# 71052-530-25, Darmerica LLC 198 Wilshire Blvd Casselberry, FL 32707

by Darmerica, LLC

Reason
Label Mix-Up: Product labeled as Quinacrine Dihydrochloride; however, after testing, identified as Artemisinin.
Published
October 2, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: April 10, 2023Historical recordClass III

Zarontin (ethosuximide capsules, USP) 250 mg, 100-count bottle, Rx Onl,y Made in Netherlands Distributed by Parke-Davis Division of Pfizer In NY, NY 10017, NDC 0071-0237-24

by Pfizer Inc.

Reason
Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.
Published
October 2, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: April 10, 2023Historical recordClass III

ethosuximide capsules, USP, 250 mg, 100-count bottle, Rx Only, Distributed by: Greenstone LLC Peapack, NJ 07977 Made in Netherlands. NDC 59762-2250-2

by Pfizer Inc.

Reason
Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.
Published
October 2, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 16, 2022Historical recordClass II

Allergy (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 30-count cartons, DISCOUNT drug mart FOOD FAIR, Distributed by: Discount Drug Mart, 211 Commerce Drive, Medina, OH 44256, NDC 53943-021-09.

by Aurolife Pharma, LLC

Reason
Failed Impurities/Degradation Specifications
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 16, 2022Historical recordClass II

Wal-Fex (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 5-count cartons, Distributed By: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, NDC 0363-0097-55.

by Aurolife Pharma, LLC

Reason
Failed Impurities/Degradation Specifications
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 16, 2022Historical recordClass II

Allergy (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 30-count bottles, Distributed by: Aurohealth LLC, 2572 Brunswick Pike, Lawrenceville, NJ 08648; NDC 58602-820-09.

by Aurolife Pharma, LLC

Reason
Failed Impurities/Degradation Specifications
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 16, 2022Historical recordClass II

Fexofenadine HCL Tablets USP, 180 mg, 500's BRITE STOCK; Manufactured for: Aurohealth LLC., 2572 Brunswick Pike, Lawrenceville, NJ 08648; Manufactured by: Aurolife Pharma LLC, Dayton, NJ 08810.

by Aurolife Pharma, LLC

Reason
Failed Impurities/Degradation Specifications
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 16, 2022Historical recordClass II

Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 15-count cartons (NDC 62011-0315-1); and b) 30-count cartons (NDC 62011-0315-2) HealthMart PHARMACY, Distributed by McKesson, One Post Street, San Francisco, CA 94104.

by Aurolife Pharma, LLC

Reason
Failed Impurities/Degradation Specifications
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 16, 2022Historical recordClass II

Allergy Relief (Fexofenadine HCl) tablets USP, 180 mg, 15-count cartons, equate, Distributed by: Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-995-62.

by Aurolife Pharma, LLC

Reason
Failed Impurities/Degradation Specifications
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 16, 2022Historical recordClass II

Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 30-count carton (NDC 70677-0008-2) and b) 15-count carton (NDC 70677-0008-1), sunmark, Distributed by McKesson, One Post Street, San Francisco, CA 94104.

by Aurolife Pharma, LLC

Reason
Failed Impurities/Degradation Specifications
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 16, 2022Historical recordClass II

fexofenadine hydrochloride tablets USP, 180 mg, 150-count bottle, Member's Mark, Distributed by: Sam's West, Inc., Bentonville, AR 22716, NDC 68196-976-91, UPC 0 78742 23550 9.

by Aurolife Pharma, LLC

Reason
Failed Impurities/Degradation Specifications
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 16, 2022Historical recordClass II

Allergy Relief (fexofenadine hydrochrloride) tablets, 180 mg, 5-count carton, Good Neighbor Pharmacy, Distributed By Amerisource Bergen, 1300 Morris Drive, Chesterbrook, PA 19087, NDC 46122-387-23.

by Aurolife Pharma, LLC

Reason
Failed Impurities/Degradation Specifications
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 16, 2022Historical recordClass II

Allergy Relief (Fexofenadine Hydrochrloride) Tablets USP, 180 mg, packaged in a) 15-count cartons (NDC 60000-409-53); b) 30-count cartons (NDC 60000-409-30); c) 45-count bonus cartons (NDC 60000-409-48); d) 45-count cartons (NDC 60000-409-45); CAREone, Distributed by: Foodhold U.S.A., LLC, Landover, MD 20785.

by Aurolife Pharma, LLC

Reason
Failed Impurities/Degradation Specifications
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 16, 2022Historical recordClass II

Fexofenadine Hydrochrloride Tablets USP, 180 mg, 100-count bottle, Distributed by: Aurohealth LLC., 2572 Brunswick Pike, Lawrenceville, NJ 08648, NDC 58602-711-21

by Aurolife Pharma, LLC

Reason
Failed Impurities/Degradation Specifications
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 15, 2022Historical recordClass II

Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL per bottle, Rx Only, Distr. by: West-Ward Pharmaceuticals,Eatontown, NJ. NDC:0054-0199-59

by West-Ward Columbus Inc

Reason
Failed Impurities/Degradation Specificattion
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 3, 2020Historical recordClass II

Anagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-453-01.

by Torrent Pharma Inc.

Reason
Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: July 12, 2023Historical recordClass II

Soothing Sore Relief (lidocaine) Liquid Gel, 4%, packaged in a) 1 Oz (NDC 69804-077-14), b) 2 Oz (NDC 69804-077-15), and c) 4 Oz (NDC 69804-077-16) bottles, OTC, Manufactured, packed & distributed by Pain Relief Naturally, Salem, OR 97301.

by Ridge Properties, LLC

Reason
Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: July 12, 2023Historical recordClass II

Soothing Sore Relief (lidocaine) Cream, 4%, packaged in a) 1 OZ (NDC 69804-074-05), b) 2 OZ (NDC 69804-074-02), and c) 4 OZ (NDC 69804-074-03) jars, OTC, Manufactured, packed & distributed by Pain Relief Naturally, Salem, OR 97301.

by Ridge Properties, LLC

Reason
Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: July 12, 2023Historical recordClass II

Superior Pain & Itch Relief (lidocaine) Liquid Gel, 4%, packaged in a) 1 Oz (NDC 69804-073-14), b) 2 Oz (NDC 69804-073-15), and c) 4 Oz (NDC 69804-073-16) bottles, OTC, Manufactured, packed & distributed by Pain Relief Naturally, Salem, OR 97301.

by Ridge Properties, LLC

Reason
Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: July 12, 2023Historical recordClass II

Superior Pain & Itch Relief (lidocaine) Cream, 4%, packaged in a) 1 OZ (NDC 69804-070-05), b) 2 OZ (NDC 69804-070-02), and c) 4 OZ (NDC 69804-070-03) jars, OTC, Manufactured, packed & distributed by Pain Relief Naturally, Salem, OR 97301.

by Ridge Properties, LLC

Reason
Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.
Published
September 25, 2019
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.